US3856818A - Tricyclic phenoxy aminopropanols - Google Patents
Tricyclic phenoxy aminopropanols Download PDFInfo
- Publication number
- US3856818A US3856818A US00268313A US26831372A US3856818A US 3856818 A US3856818 A US 3856818A US 00268313 A US00268313 A US 00268313A US 26831372 A US26831372 A US 26831372A US 3856818 A US3856818 A US 3856818A
- Authority
- US
- United States
- Prior art keywords
- lower alkyl
- tetrahydro
- cis
- amino
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- UJUKHOATWVVDER-UHFFFAOYSA-N 1-amino-1-phenoxypropan-1-ol Chemical class CCC(N)(O)OC1=CC=CC=C1 UJUKHOATWVVDER-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 62
- 125000000217 alkyl group Chemical group 0.000 claims description 67
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- -1 polymethylene phenoxyaminopropanols Polymers 0.000 abstract description 67
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 24
- 150000003839 salts Chemical class 0.000 abstract description 10
- 239000003874 central nervous system depressant Substances 0.000 abstract description 3
- 125000004122 cyclic group Chemical group 0.000 abstract description 3
- 230000005764 inhibitory process Effects 0.000 abstract description 3
- 230000036772 blood pressure Effects 0.000 abstract description 2
- 208000029078 coronary artery disease Diseases 0.000 abstract description 2
- 230000007797 corrosion Effects 0.000 abstract description 2
- 238000005260 corrosion Methods 0.000 abstract description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 35
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 30
- KFZMGEQAYNKOFK-UHFFFAOYSA-N 2-propanol Substances CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 28
- 239000000203 mixture Substances 0.000 description 27
- 239000000243 solution Substances 0.000 description 27
- 238000000034 method Methods 0.000 description 26
- 229960004592 isopropanol Drugs 0.000 description 24
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 23
- 239000001257 hydrogen Substances 0.000 description 21
- 229910052739 hydrogen Inorganic materials 0.000 description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- 239000002904 solvent Substances 0.000 description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 16
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- 125000003545 alkoxy group Chemical group 0.000 description 14
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 13
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 13
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- 229910052757 nitrogen Inorganic materials 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical compound C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 description 11
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 11
- 150000002431 hydrogen Chemical class 0.000 description 10
- 239000007787 solid Substances 0.000 description 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 229960000583 acetic acid Drugs 0.000 description 8
- 230000003197 catalytic effect Effects 0.000 description 7
- 150000002009 diols Chemical class 0.000 description 7
- 229960000443 hydrochloric acid Drugs 0.000 description 7
- 235000011167 hydrochloric acid Nutrition 0.000 description 7
- 238000010992 reflux Methods 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- 239000004593 Epoxy Substances 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 238000006264 debenzylation reaction Methods 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 6
- 235000011054 acetic acid Nutrition 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 5
- 239000002002 slurry Substances 0.000 description 5
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 4
- 125000003342 alkenyl group Chemical group 0.000 description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- 239000011630 iodine Substances 0.000 description 4
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 4
- 229910052763 palladium Inorganic materials 0.000 description 4
- 125000002112 pyrrolidino group Chemical group [*]N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 description 4
- 229940071536 silver acetate Drugs 0.000 description 4
- 239000008096 xylene Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- WEMVUAWJIMHKNG-UHFFFAOYSA-N 3-phenylmethoxy-1a,2,7,7a-tetrahydronaphtho[2,3-b]oxirene Chemical compound C=1C=CC=2CC3OC3CC=2C=1OCC1=CC=CC=C1 WEMVUAWJIMHKNG-UHFFFAOYSA-N 0.000 description 3
- OAHLLHJOPUWLKW-UHFFFAOYSA-N 5,8-dihydronaphthalen-1-ol Chemical compound C1C=CCC2=C1C=CC=C2O OAHLLHJOPUWLKW-UHFFFAOYSA-N 0.000 description 3
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 3
- QWOJMRHUQHTCJG-UHFFFAOYSA-N CC([CH2-])=O Chemical compound CC([CH2-])=O QWOJMRHUQHTCJG-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical class O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 125000003710 aryl alkyl group Chemical group 0.000 description 3
- 125000000753 cycloalkyl group Chemical group 0.000 description 3
- 150000002118 epoxides Chemical class 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 239000012458 free base Substances 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 125000005936 piperidyl group Chemical group 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical compound CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 description 3
- MXZROAOUCUVNHX-UHFFFAOYSA-N 2-Aminopropanol Chemical compound CCC(N)O MXZROAOUCUVNHX-UHFFFAOYSA-N 0.000 description 2
- SLDXQJKDITYTDE-UHFFFAOYSA-N 5,8-dihydronaphthalen-2-ol Chemical compound C1C=CCC2=CC(O)=CC=C21 SLDXQJKDITYTDE-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- 239000000538 analytical sample Substances 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000010533 azeotropic distillation Methods 0.000 description 2
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- LIMQQADUEULBSO-UHFFFAOYSA-N butyl isothiocyanate Chemical compound CCCCN=C=S LIMQQADUEULBSO-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- IBIKHMZPHNKTHM-RDTXWAMCSA-N merck compound 25 Chemical compound C1C[C@@H](C(O)=O)[C@H](O)CN1C(C1=C(F)C=CC=C11)=NN1C(=O)C1=C(Cl)C=CC=C1C1CC1 IBIKHMZPHNKTHM-RDTXWAMCSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- KHUXNRRPPZOJPT-UHFFFAOYSA-N phenoxy radical Chemical class O=C1C=C[CH]C=C1 KHUXNRRPPZOJPT-UHFFFAOYSA-N 0.000 description 2
- 125000004193 piperazinyl group Chemical group 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 229920006395 saturated elastomer Chemical class 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 238000001665 trituration Methods 0.000 description 2
- LCGFVWKNXLRFIF-UHFFFAOYSA-N 1,2,3,4-tetrahydronaphthalen-2-amine Chemical compound C1=CC=C2CC(N)CCC2=C1 LCGFVWKNXLRFIF-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- RMSGQZDGSZOJMU-UHFFFAOYSA-N 1-butyl-2-phenylbenzene Chemical group CCCCC1=CC=CC=C1C1=CC=CC=C1 RMSGQZDGSZOJMU-UHFFFAOYSA-N 0.000 description 1
- MNZAKDODWSQONA-UHFFFAOYSA-N 1-dibutylphosphorylbutane Chemical compound CCCCP(=O)(CCCC)CCCC MNZAKDODWSQONA-UHFFFAOYSA-N 0.000 description 1
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 1
- HEWZVZIVELJPQZ-UHFFFAOYSA-N 2,2-dimethoxypropane Chemical compound COC(C)(C)OC HEWZVZIVELJPQZ-UHFFFAOYSA-N 0.000 description 1
- 125000001894 2,4,6-trinitrophenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1[N+]([O-])=O)[N+]([O-])=O)[N+]([O-])=O 0.000 description 1
- 125000003456 2,6-dinitrophenyl group Chemical group [H]C1=C([H])C(=C(*)C(=C1[H])[N+]([O-])=O)[N+]([O-])=O 0.000 description 1
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 1
- QQZOPKMRPOGIEB-UHFFFAOYSA-N 2-Oxohexane Chemical compound CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-M 2-methylbenzenesulfonate Chemical compound CC1=CC=CC=C1S([O-])(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-M 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000006325 2-propenyl amino group Chemical group [H]C([H])=C([H])C([H])([H])N([H])* 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- OROGUZVNAFJPHA-UHFFFAOYSA-N 3-hydroxy-2,4-dimethyl-2H-thiophen-5-one Chemical compound CC1SC(=O)C(C)=C1O OROGUZVNAFJPHA-UHFFFAOYSA-N 0.000 description 1
- YAXGBZDYGZBRBQ-UHFFFAOYSA-N 4,5-dihydro-1,3-oxazol-2-amine Chemical class NC1=NCCO1 YAXGBZDYGZBRBQ-UHFFFAOYSA-N 0.000 description 1
- UMKXSOXZAXIOPJ-UHFFFAOYSA-N 5,6,7,8-tetrahydro-2-naphthol Chemical compound C1CCCC2=CC(O)=CC=C21 UMKXSOXZAXIOPJ-UHFFFAOYSA-N 0.000 description 1
- CZNJCCVKDVCRKF-UHFFFAOYSA-N Benzyl sulfate Chemical compound OS(=O)(=O)OCC1=CC=CC=C1 CZNJCCVKDVCRKF-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 229940099408 Oxidizing agent Drugs 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000006323 alkenyl amino group Chemical group 0.000 description 1
- 125000005036 alkoxyphenyl group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- NQOIPEBCWBNSJS-UHFFFAOYSA-N benzoyl chloride;pyridine Chemical compound C1=CC=NC=C1.ClC(=O)C1=CC=CC=C1 NQOIPEBCWBNSJS-UHFFFAOYSA-N 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 102000012740 beta Adrenergic Receptors Human genes 0.000 description 1
- 108010079452 beta Adrenergic Receptors Proteins 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- 125000004799 bromophenyl group Chemical group 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000004369 butenyl group Chemical class C(=CCC)* 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- NEHMKBQYUWJMIP-NJFSPNSNSA-N chloro(114C)methane Chemical compound [14CH3]Cl NEHMKBQYUWJMIP-NJFSPNSNSA-N 0.000 description 1
- 125000000068 chlorophenyl group Chemical group 0.000 description 1
- 229940001468 citrate Drugs 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 125000006264 diethylaminomethyl group Chemical group [H]C([H])([H])C([H])([H])N(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 125000001207 fluorophenyl group Chemical group 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 125000005059 halophenyl group Chemical group 0.000 description 1
- 125000000268 heptanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006038 hexenyl group Chemical class 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000011872 intimate mixture Substances 0.000 description 1
- 125000006303 iodophenyl group Chemical group 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical group CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- NBTOZLQBSIZIKS-UHFFFAOYSA-N methoxide Chemical compound [O-]C NBTOZLQBSIZIKS-UHFFFAOYSA-N 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 239000010705 motor oil Substances 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 125000004365 octenyl group Chemical class C(=CCCCCCC)* 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- AUONHKJOIZSQGR-UHFFFAOYSA-N oxophosphane Chemical compound P=O AUONHKJOIZSQGR-UHFFFAOYSA-N 0.000 description 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 125000002255 pentenyl group Chemical class C(=CCCC)* 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 125000004368 propenyl group Chemical class C(=CC)* 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 229940086735 succinate Drugs 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- ZWZVWGITAAIFPS-UHFFFAOYSA-N thiophosgene Chemical compound ClC(Cl)=S ZWZVWGITAAIFPS-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/92—Naphthofurans; Hydrogenated naphthofurans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/60—Naphthoxazoles; Hydrogenated naphthoxazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
- C07D303/26—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds having one or more free hydroxyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/22—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one naphthalene or hydrogenated naphthalene ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/74—Naphthothiophenes
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2215/00—Organic non-macromolecular compounds containing nitrogen as ingredients in lubricant Compositions
- C10M2215/02—Amines, e.g. polyalkylene polyamines; Quaternary amines
- C10M2215/04—Amines, e.g. polyalkylene polyamines; Quaternary amines having amino groups bound to acyclic or cycloaliphatic carbon atoms
- C10M2215/042—Amines, e.g. polyalkylene polyamines; Quaternary amines having amino groups bound to acyclic or cycloaliphatic carbon atoms containing hydroxy groups; Alkoxylated derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2215/00—Organic non-macromolecular compounds containing nitrogen as ingredients in lubricant Compositions
- C10M2215/086—Imides [having hydrocarbon substituents containing less than thirty carbon atoms]
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2215/00—Organic non-macromolecular compounds containing nitrogen as ingredients in lubricant Compositions
- C10M2215/22—Heterocyclic nitrogen compounds
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2215/00—Organic non-macromolecular compounds containing nitrogen as ingredients in lubricant Compositions
- C10M2215/22—Heterocyclic nitrogen compounds
- C10M2215/221—Six-membered rings containing nitrogen and carbon only
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2215/00—Organic non-macromolecular compounds containing nitrogen as ingredients in lubricant Compositions
- C10M2215/22—Heterocyclic nitrogen compounds
- C10M2215/225—Heterocyclic nitrogen compounds the rings containing both nitrogen and oxygen
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2215/00—Organic non-macromolecular compounds containing nitrogen as ingredients in lubricant Compositions
- C10M2215/22—Heterocyclic nitrogen compounds
- C10M2215/225—Heterocyclic nitrogen compounds the rings containing both nitrogen and oxygen
- C10M2215/226—Morpholines
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2215/00—Organic non-macromolecular compounds containing nitrogen as ingredients in lubricant Compositions
- C10M2215/24—Organic non-macromolecular compounds containing nitrogen as ingredients in lubricant Compositions having hydrocarbon substituents containing thirty or more carbon atoms, e.g. nitrogen derivatives of substituted succinic acid
- C10M2215/28—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2215/00—Organic non-macromolecular compounds containing nitrogen as ingredients in lubricant Compositions
- C10M2215/24—Organic non-macromolecular compounds containing nitrogen as ingredients in lubricant Compositions having hydrocarbon substituents containing thirty or more carbon atoms, e.g. nitrogen derivatives of substituted succinic acid
- C10M2215/30—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2219/00—Organic non-macromolecular compounds containing sulfur, selenium or tellurium as ingredients in lubricant compositions
- C10M2219/08—Thiols; Sulfides; Polysulfides; Mercaptals
- C10M2219/082—Thiols; Sulfides; Polysulfides; Mercaptals containing sulfur atoms bound to acyclic or cycloaliphatic carbon atoms
- C10M2219/084—Thiols; Sulfides; Polysulfides; Mercaptals containing sulfur atoms bound to acyclic or cycloaliphatic carbon atoms containing hydroxy groups; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2219/00—Organic non-macromolecular compounds containing sulfur, selenium or tellurium as ingredients in lubricant compositions
- C10M2219/09—Heterocyclic compounds containing no sulfur, selenium or tellurium compounds in the ring
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2219/00—Organic non-macromolecular compounds containing sulfur, selenium or tellurium as ingredients in lubricant compositions
- C10M2219/10—Heterocyclic compounds containing sulfur, selenium or tellurium compounds in the ring
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2219/00—Organic non-macromolecular compounds containing sulfur, selenium or tellurium as ingredients in lubricant compositions
- C10M2219/10—Heterocyclic compounds containing sulfur, selenium or tellurium compounds in the ring
- C10M2219/102—Heterocyclic compounds containing sulfur, selenium or tellurium compounds in the ring containing sulfur and carbon only in the ring
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2219/00—Organic non-macromolecular compounds containing sulfur, selenium or tellurium as ingredients in lubricant compositions
- C10M2219/10—Heterocyclic compounds containing sulfur, selenium or tellurium compounds in the ring
- C10M2219/104—Heterocyclic compounds containing sulfur, selenium or tellurium compounds in the ring containing sulfur and carbon with nitrogen or oxygen in the ring
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2219/00—Organic non-macromolecular compounds containing sulfur, selenium or tellurium as ingredients in lubricant compositions
- C10M2219/10—Heterocyclic compounds containing sulfur, selenium or tellurium compounds in the ring
- C10M2219/104—Heterocyclic compounds containing sulfur, selenium or tellurium compounds in the ring containing sulfur and carbon with nitrogen or oxygen in the ring
- C10M2219/106—Thiadiazoles
Definitions
- ABSTRACT This invention relates to new cyclic polymethylene phenoxy-aminopropanols and related compounds of the formula and to salts of such compounds, which are useful in coronary diseases, lowering blood pressure, as central nervous system depressants, water softening and corrosion inhibition.
- the radical is a basic nitrogen containing radical of up to about 18 carbon
- R is hydrogen, lower alkyl or aralkyl and n is O, l or 2.
- R and the hydrogen attached to the oxygen will be deleted.
- R' and R can be the same or different and can be hydrogen, lower alkyl, aryl, hydroxy. alkoxy, aryloxy or amino and n is l or 2.
- lower alkyl as employed herein includes both straight and branched chain radicals of up to and including eight carbon atoms, for instance, methyl, ethyl, propyl, isopropyl, butyl, s-butyl, t-butyl, isobutyl, pentyl, hexyl, isohexyl, heptyl, 4,4-dimethylpentyl, oc tyl, 2,2,4-trimethylpentyl and the like.
- the aryl-lower alkyl groups include benzyl, phenethyl and the like.
- lower alkoxy includes straight and branched chain radicals of the structure RO- wherein R includes any of the above lower alkyl groups.
- halogen includes each of the four halogens, but Cl and Br are preferred.
- the amino groups include unsubstituted amino or monoor di-lower alkyl-amino groups, wherein lower alkyl is as defined above, such as amino, methyl amino, ethyl amino, isopropyl amino, heptylamino, dimethyl amino, diethyl amino, methyl ethyl amino, methyl butyl amino, ethyl i-propyl amino and the like.
- the acyl radicals represented by R include lower fatty acid radicals such as acetyl, propionyl, butyryl, isobutyryl and the like, as well as long chain fatty acid radicals such as hexanoyl, heptanoyl, decanoyl, dodecanoyl and the like, monocyclic aryl and aralkanoic acid radicals such as benzoyl, phenacetyl and the like.
- lower alkenyl refers to C to C aliphatic groups which include one double bond such as ally] and all isomers of propenyl, butenyl, pentenyl, hexenyl, heptenyl and octenyl.
- monocyclic aryl as employed herein contemplates monocyclic carbocyclic aryl radicals, for instance, phenyl and substituted phenyl radicals, such as lower alkyl phenyl (e.g., 0-, mor p-tolyl, ethylphenyl, butylphenyl and the like, di(lower alkyl)phenyl (e.g., 2,4-dimethylphenyl, 3,5-diethylphenyl and the like) halophenyl (e.g., chlorophenyl, bromophenyl, iodophenyl, fluorophenyl), o-, mor p-nitrophenyl, dinitrophenyl, (e.g., 3,5-dinitrophenyl, 2,6- dinitrophenyl and the like), and trinitrophenyl (e.g., picryl) and alkoxyphenyl such as methoxyphenyl.
- monocyclic cycloalkyl includes cyclic radicals containing from 3 to 6 ring members (e.g., cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl).
- R and R each represents hydrogen, lower alkyl, lower alkenyl, hydroxy-lower alkyl and phenyllower alkyl forming such basic groups as amino, lower alkylamino, e.g., methylamino, ethylamino, isopropylamino, di(lower alkyl)amino, e.g., dimethyl- LII amino, diethylamino, dipropylamino, lower alkenylamino, e.g., allylamino, di(lower alkenyl)amino, e.g., diallylamino, (hydroxy-lower alkyl)amino, e.g., hydroxyethylamino, di(hydroxy-lower alkyl)amino, e.g., di(hydroxyethyl)amino, phenyl(lower alkyl- )amino, e.g.
- radical may form a heterocyclic radical.
- R and R may together represent the carbon (and hydrogen) and the oxygen, sulfur or nitrogen atoms which, with the nitrogen or carbon atom in the above group, form a or 6-membered nitrogen heterocyclic containing not more than one hetero atom in addition to the nitrogen already shown in the group and less than 21 atoms in the radical (excluding hydrogen).
- the heterocyclic radicals may include one to three substituents including lower alkoxy or lower alkyl as defined hereinbefore; trifluoromethoxy; trifluoromethylmercapto; N,N-dialkylsulfamoyl groups, such as N,N-dimethylsulfamoyl; lower alkanoyl groups where R is lower alkyl) as defined hereinbefore, such asacetyl, propionyl, and the like; hydroxy-lower alkyl, such as hydroxymethyl,2-hydroxyethyl or the like; hydroxy-lower alkoxy-lower alkyl, such as 2-(2-hydroxyethoxy)ethyl, or the like; lower alkanoyl-lower alkyl, such as Z-heptanoyloxyethyl; carbolower alkoxy, such as carbomethoxy, carboethoxy, carbopropoxy, or the like; or'2-(lower alkanoyloxy-lower alkoxy)low
- heterocyclic radicals represented by 31 are the following: piperidino; (lower alkyl)piperidino [e.g., 2-, 3-, or 4-(lower alkyl)piperidino or 4-(N-lower alkyl )-piperidino, such as 2-(ethyl)piperidino or 4-(N- isopropyl)-piperidino]; di(lower alkyl)piperidino [e.g., 2,4-, 2,5- or 3,5-di(lower alkyl)piperidino, such as 2,4- dimethyl piperidino or 2,5-di-t-butyl piperidino]; (lower alkoxy)piperidino [e.g., 2-methoxypiperidino or 3-methoxypiperidino]; hydroxypiperidino [e.g., 3-
- hydroxy- 'or 4-hydroxypiperidino ; aminomethylpiperidino [e.g., 4-aminomethylpiperidino]; pyrrolidino; (lower alkyl)pyrrolidino [e.g., 3-
- methylpyrrolidino di(lower alkyl)pyrrolidino [e.g., 3,4-dimethylpyrrolidino];- (lower alkoxy)pyrrolidino [e.g., 2-methoxypyrrolidino]; morpholino; (lower alkyl)morpholino [e.g., 3-methylmorpholino]; di(lower alkyl)morpholino, [e.g., 3,5-dimethylmorpholino]; (lower alkoxy)-morpholino, [e.g., 2- methoxymorpholino]; thiamorpholino; (lower alkyl)- thiamorpholino [e.g., 3-methylthiamorpholino]; di(- lower alkyl)thiamorpholino, [e.g., 3,5- dimethylthiamorpholino], (lower alkoxy)thiamorpholino, [e.g., 3-methoxythiamorpholino]; piperazino;
- lower alkyl is methyl, ethyl, n-propyl, isopropyl, etc]; lower alkoxy piperidyl, [e.g., 3-methoxypiperidyl or 2- 4 ethoxypiperidyl]; hydroxypiperidyl [e.g., 3-hydroxyor 4-hydroxypiperidyl]; aminomethylpiperidyl,[e. g.
- pyrrolidyl lower alkyl pyrrolidyl, [e.g., l-N-methylpyrrolidyl]; di(lower alkyl)pyrrolidyl, [e.g., 2,3-dimethylpyrrolidyl]; lower alkoxy pyrrolidyl, [e.g, 4-N-methoxypyrrolidyl]; morpholinyl; (lower alkyl)-morpholinyl, [e.g., 3- methylmorpholinyl]; di-(lower alkyl)-morph0linyl, [e.g., 3-methyl-4-N-ethylmorpholinyl1; (lower alkoxy)- morpholinyl, [e.g, 2-ethoxymorpholinyl]; thiamorpholinyl; (lower alkyl)thiamorpholino, [e.g., 3- eth
- the compounds of formula I form acid addition salts with inorganic and organic acids. These acid addition salts frequently provide useful means for isolating the products from reaction mixtures by forming the salt in a medium in which it is insoluble.- The free base may then be obtained by neutralization, e.g., with a base such as sodium hydroxide. Then any other salt may again be formed from the free base and the appropriate inorganic or organic acid.
- hydrohalides especially the hydrochloride and hydrobromide which are preferred, sulfate, nitrate, phosphate, borate, acetate, oxalate, tartrate, maleate, citrate, succinate, benzoate, ascorbate, salicylate, methanesulfonate, benzenesulfonate, toluenesulfonate and the like.
- Quaternary ammonium salts are also formed, e.g., by reacting the free base with an alkylating agent, e.g., lower alkyl halide such as methyl chloride, ethyl bromide or the like, lower alkyl sulfate such as methyl sulfate, aralkyl halides such as benzyl chloride, aralkyl sulfates such as benzyl sulfate and the like.
- an alkylating agent e.g., lower alkyl halide such as methyl chloride, ethyl bromide or the like
- lower alkyl sulfate such as methyl sulfate
- aralkyl halides such as benzyl chloride
- aralkyl sulfates such as benzyl sulfate and the like.
- R, R, R R R R R, R and R are all hydrogen, R is hydrogen or lower alkyl especially hydrogen, R is lower alkyl, especially isopropyl, and X is O, Y is O and Z is and the aminopropanol C me 1- or a-position.
- the X-Z-Y group will be attached to the cycloalkyl ring on two vicinal carbon atoms.
- the new compounds of this invention are useful as water softeners and for inhibiting the corrosivity of engine lubricants.
- a compound of formula I or a physiologically acceptable acid addition salt may be incorporated in a conventional dosage form such as tablet, capsule, elixir, injectable or the like along with the necessary carrier material, excipient, lubricant, buffer or the like.
- Single or divided doses of about 5 to 25 mg/kg/day, preferably about 4 to 10 mg/kg, two to four times daily may be administered in dosage forms as described above.
- the above epoxy-propoxy-naphthalene can be converted to the formula I compounds of the invention by heating with an amine VII R H R2 in an inert organic solvent, such as n-propanol, benzene or toluene, e.g., for about 16 to 24 hours; the reactants may also be heated in a Parr pressure reactor at a temperature within the range of from about 70 to about 1 10 for 6 12 Compounds of formulae 1 and Ill wherein Z is prescut
- compounds of structure I can be pre- I pared by reacting a starting material of structure [V with a compound of the structure XII XII R6 R1 R3 of the R4 l I which are epoxidized by reaction with a suitable oxidizingagent such as m-chloroperbenzoic acid or other peracid in a solvent such as chloroform. to compounds of structure Vl.
- a suitable oxidizingagent such as m-chloroperbenzoic acid or other peracid in a solvent such as chloroform.
- Preferred compounds of the invention include those having the structure to form ethers XIII structure Rn X EXAMPLE 1 3a.9a-cis-1-(tert-Butylamino)-3-[(3a, 4,9,9atetrahydro-Z, 2-dimethyl-2H-naphtho[2,3-d]dioxol-5- yl)-oxy]-2-propanol A. cis-5,6,7,8-Tetrahydro-1,6,7-naphthalenetriol A solution of 29.2 g. (0.2 mole) of 5,8-dihydro-1- naphthol and 40 ml. of acetic anhydride in 100 ml of pyridine is prepared.
- the haloacetal from part A is dissolved in ethanol containing excess diethylamine and the mixture heated at C for 48 hours in a bomb. The mixture is cooled and water and solvent stripped therefrom. The residue is purified bychromatography on Alumina 11 neutral to yield the title compound.
- EXAMPLE 4 3a,9a-cis-1-(iso-Propylamino)-3-[3a,4,9,9atetrahydro-2H-naphtho[2,3d]dioxol-2-one-5yl]-oxy]- 2-propanol
- 5,8-Dihydro-l-naphthol, benzyl ether A solution of 5,8-dihydro-l-naphthol (73 g., 0.5 M) in 400 ml. DMSO is treated with 0.5 M ofsodium methoxide. The mixture is cooled in an ice bath while benzyl bromide (85.5 g., 0.5 M) is added dropwise.
- the mixture has to be shaken periodically since there is difficulty in stirring. Toward the end of the addition the mixture is allowed to warm to -45", and stirring is continued for 2-3 hours after addition is complete. The mixture is then poured into 1 liter H 0 and the product is extracted into ether. The ether extracts are washed with 10% NaOH, dried and the solvent is removed in vacuo to give a' quantitative yield of crude crystalline product.
- the filtrate is taken to dryness in vacuo and the residue taken up in 250 ml of methanol and treated in the cold with a solution of 40 g of sodium hydroxide in 200 ml of water. After stirring overnight, the bulk of the methanol is removed in vacuum, and the product extracted into chloroform. After dyring and solvent removal, the product is induced to crystallize by trituration with hexane.
- the mixture is cooled in an ice bath and treated dropwise with 0.5 mole benzyl bromide with shaking periodically.
- the mixture is gradually allowed to warm up to about 45 toward the end of addition.
- the mixture is stirred 3 hrs. longer, then poured into 1 liter H 0 and extracted into ether. Extracts are washed twice with 10% NaOH, dried, taken to dryness leaving almost a quantitative yield of crystalline 5,8-dihydro-lnaphthyl benzyl ether.
- EXAMPLE 8 3a,9a-tran s-l-(iso-Propylamino)-3[3a,4,9,9atetrahydro-2-diethylaminomethyl-2H-naphtho[2,3d]- l thia-3-oxol-5(and 8)yl)-oxy]-2-propanol
- oroethylidene-6-mercapto-5,6,7,8- tetrahydronaphthalene-l .7-diol Employing the mercaptan prepared in Example 6B in lieu of cis-5,6.7.8-tetrahydro-l,6,7-naphthalenetriol in the procedure of Example 3.
- EXAMPLE ll EXAMPLE l2 3a,9a-trans-l-(iso-Propylamino)-3[(3a,4,9,9atetrahydro-2H-naphtho[2,3d]-l-thia-3-oxol-2-thion- 5(and 8)yl)oxy]-2-propanol A.
- 6-Amino-5,6,7,8-tetrahydronaphthalene dio1-O-benzyl ether O,N-thiocarbonate A solution of 0.l m each of the epoxide benzyl ether of Example 6A and butylisothiocyanate in xylene added to a solution containing 0.004 m of tributyl phosphine oxide and 0.003 m of lithium bromide in xylene and the mixture heated under reflux overnight. After cooling, solvent is removed and the crude mixture of products purified on neutral Alumina lll to give the title compound.
- the suspension was poured into a mixture of 50 ml of NaOH and 100 g of ice.
- the aqueous layer was extracted with CH Cl and the combined organic layers were washed with water and satd. NaCl soln, dried and evaporated in vacuo to give the title compound.
- the crude azide was dissolved in 100 ml of ether and added to a suspension of L'AH (5 g) in 250 ml of ether. After several hours at reflux, the mixture was decomposed with aqueous potassium carbonate and the filtrate freed of solvent.
- Aminooxazoline derivative of 6(and 7)amino- 5,6,7,8-tetrahydronaphthalene-l,7(and 6)diol An intimate mixture of 12.6 g (0.05 mole) of 6,7- epoxy-5,6,7,8-tetrahydro-l-naphthyl benzyl ether and 25 g of guanidine are heated to l40l80C until gas evolution ceases. The reaction mixture is cooled, and the product recrystallized from alcohol.
- EXAMPLE 1 7 6-Hydroxy-5(and 8)-(2-hydroxy-3-butylaminopropoxy)-5,6,7,8-tetrahydronaphthalene-7-acetic acid lactone A. 1,7(and 6)Dihydroxy-5,6,7,8-tetrahydro-6(and 7)-naphthalene-acetic acid lactone A solution of 12.6 g (0.05 mole) of 6,7-epoxy' 5,6,'7,S-tetrahydronaphthol benzyl ether and 7.5 g (0.05 mole) of diethylmalonate in ml of absolute ethanol containing about 0.01 mole of sodium ethoxide was brought to reflux for several hours. The mixture was cooled, treated with concentrated HCl and warmed to effect hydrolysis and decarboxylation. Removal of solvent left crude lactone which was purified by chromatography on silica gel.
- EXAMPLE l8 EXAMPLE l9 Bis acetonide derivative of the product of Example 1
- the product of Example 1 is dissolved in acetone in v the presence ofa catalytic amount of p-toluene sulfonic acid and the mixture is refluxed to form the title compound.
- EXAMPLE 20 The Bis-butylidene derivative of 2,3-cis-l,2,3,4- tetrahydro-5-[2-hydroxy-3-(tert-butylamino)- propoxy]-2,3-naphthalenediol A. cis-5,6,7,8-Tetrahydro-1,6,7-naphthalenetriol A solution of 29.2 g. (0.2mole) of 5,8-dihydro-lnaphthol and 40 ml. of acetic anhydride in 100 ml. of pyridine is prepared. After 16 hr. the solvent is removed in vacuo and the residue dissolved in ether and washed with 200 ml.
- phenyl-lower alkyl R and R are each hydrogen or lower alkyl; and wherein lower alkyl is alkyl having up to eight carbon atoms.
- R is lower alkyl; and R" and R are each selected from the group consisting of hydrogen and lower alkyl; and wherein lower alkyl is alkyl having up to eight carbon atoms.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Lubricants (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
This invention relates to new cyclic polymethylene phenoxyaminopropanols and related compounds of the formula AND TO SALTS OF SUCH COMPOUNDS, WHICH ARE USEFUL IN CORONARY DISEASES, LOWERING BLOOD PRESSURE, AS CENTRAL NERVOUS SYSTEM DEPRESSANTS, WATER SOFTENING AND CORROSION INHIBITION.
Description
[Jite States Patent [191 Hauclr et al.
[111 3,856,818 Dec. 24,1974
[ TRICYCLIC PHENOXY AMINOPROPANOLS [75] Inventors: Frederic Peter Hauck, Somerville;
Christopher Michael Cimarusti, Somerset, both of NJ.
[73] Assignee: E. R. Squibb & Sons, Inc.,
Princeton, NJ.
[22] Filed: July 3, 1972 [2l] Appl. No.: 268,313
[56] References Cited 8 UNITED STATES PATENTS 3/1966 8/1969 Koppe 260/3405 Primary Examiner-Richard J. Gallagher Assistant Examiner-James H. Turnipseed Attorney, Agent, or F [rm-Lawrence S. Levinson; Merle J. Smith; Donald J. Barrack van Proosdij-Hartzema.... 260/340.5
[57] ABSTRACT This invention relates to new cyclic polymethylene phenoxy-aminopropanols and related compounds of the formula and to salts of such compounds, which are useful in coronary diseases, lowering blood pressure, as central nervous system depressants, water softening and corrosion inhibition.
6 Claims, N0 Drawings TlRlCYClLIC PHENOXY AMINOPROPANOLS This invention relates to new chemical compounds of the formula 1).. m M and salts thereof, wherein XZY together with two carbons of the cycloalkyl ring form a to 7-membered ring, R, R R R and R are the same or different and can be hydrogen or lower alkyl, R, R and R" are the same or different and can be hydrogen, lower alkyl, aralkyl, lower alkoxy, carboxy, monocyclic cycloalkyl, lower alkenyl, nitro, halogen, acyl, amino, acylamino, RO(CH ),,I where R is hydrogen, lower alkyl or aralkyl and n is 0 or l; X and Y may be the same or different and can be CH =N, O*, -S, NR"-, O-CH SCH or NR- CH where R is hydrogen, lower alkyl or aryl, Z can be I V a BQWMBJZ, where R and R can be hydrogen, lower alkyl, cycloalkyl, aryl. haloalkyl, amino or 'aminoalkyl;
o-cm-; -o-c ll ll ll a. V 9c-9 and X-ZY- can be taken together to form O-C=N or -S-C=N--, 've
the radical is a basic nitrogen containing radical of up to about 18 carbon, R is hydrogen, lower alkyl or aralkyl and n is O, l or 2.
Where in Formula I the O-Z N group is present, then, in such case, R and the hydrogen attached to the oxygen will be deleted. Thus, the present invention inwherein R' and R can be the same or different and can be hydrogen, lower alkyl, aryl, hydroxy. alkoxy, aryloxy or amino and n is l or 2.
The term lower alkyl as employed herein includes both straight and branched chain radicals of up to and including eight carbon atoms, for instance, methyl, ethyl, propyl, isopropyl, butyl, s-butyl, t-butyl, isobutyl, pentyl, hexyl, isohexyl, heptyl, 4,4-dimethylpentyl, oc tyl, 2,2,4-trimethylpentyl and the like.
The aryl-lower alkyl groups include benzyl, phenethyl and the like.
The term lower alkoxy includes straight and branched chain radicals of the structure RO- wherein R includes any of the above lower alkyl groups.
The term halogen includes each of the four halogens, but Cl and Br are preferred.
The amino groups include unsubstituted amino or monoor di-lower alkyl-amino groups, wherein lower alkyl is as defined above, such as amino, methyl amino, ethyl amino, isopropyl amino, heptylamino, dimethyl amino, diethyl amino, methyl ethyl amino, methyl butyl amino, ethyl i-propyl amino and the like.
The acyl radicals represented by R include lower fatty acid radicals such as acetyl, propionyl, butyryl, isobutyryl and the like, as well as long chain fatty acid radicals such as hexanoyl, heptanoyl, decanoyl, dodecanoyl and the like, monocyclic aryl and aralkanoic acid radicals such as benzoyl, phenacetyl and the like.
The term lower alkenyl" refers to C to C aliphatic groups which include one double bond such as ally] and all isomers of propenyl, butenyl, pentenyl, hexenyl, heptenyl and octenyl.
The term monocyclic aryl as employed herein contemplates monocyclic carbocyclic aryl radicals, for instance, phenyl and substituted phenyl radicals, such as lower alkyl phenyl (e.g., 0-, mor p-tolyl, ethylphenyl, butylphenyl and the like, di(lower alkyl)phenyl (e.g., 2,4-dimethylphenyl, 3,5-diethylphenyl and the like) halophenyl (e.g., chlorophenyl, bromophenyl, iodophenyl, fluorophenyl), o-, mor p-nitrophenyl, dinitrophenyl, (e.g., 3,5-dinitrophenyl, 2,6- dinitrophenyl and the like), and trinitrophenyl (e.g., picryl) and alkoxyphenyl such as methoxyphenyl.
' The terms monocyclic cycloalkyl includes cyclic radicals containing from 3 to 6 ring members (e.g., cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl).
In the basic nitrogen containing radical in formula I, R and R each represents hydrogen, lower alkyl, lower alkenyl, hydroxy-lower alkyl and phenyllower alkyl forming such basic groups as amino, lower alkylamino, e.g., methylamino, ethylamino, isopropylamino, di(lower alkyl)amino, e.g., dimethyl- LII amino, diethylamino, dipropylamino, lower alkenylamino, e.g., allylamino, di(lower alkenyl)amino, e.g., diallylamino, (hydroxy-lower alkyl)amino, e.g., hydroxyethylamino, di(hydroxy-lower alkyl)amino, e.g., di(hydroxyethyl)amino, phenyl(lower alkyl- )amino, e.g., benzylamino, phenethylamino, N-(lower alkyl)phenyl(lower alkyl)amino, e.g., N- methylbenzylamino, and the like.
The
radical may form a heterocyclic radical. The symbols R and R may together represent the carbon (and hydrogen) and the oxygen, sulfur or nitrogen atoms which, with the nitrogen or carbon atom in the above group, form a or 6-membered nitrogen heterocyclic containing not more than one hetero atom in addition to the nitrogen already shown in the group and less than 21 atoms in the radical (excluding hydrogen). The heterocyclic radicals may include one to three substituents including lower alkoxy or lower alkyl as defined hereinbefore; trifluoromethoxy; trifluoromethylmercapto; N,N-dialkylsulfamoyl groups, such as N,N-dimethylsulfamoyl; lower alkanoyl groups where R is lower alkyl) as defined hereinbefore, such asacetyl, propionyl, and the like; hydroxy-lower alkyl, such as hydroxymethyl,2-hydroxyethyl or the like; hydroxy-lower alkoxy-lower alkyl, such as 2-(2-hydroxyethoxy)ethyl, or the like; lower alkanoyl-lower alkyl, such as Z-heptanoyloxyethyl; carbolower alkoxy, such as carbomethoxy, carboethoxy, carbopropoxy, or the like; or'2-(lower alkanoyloxy-lower alkoxy)lower alkyl such as Z-(decanoyloxyethoxy)ethyl, or thelike,
Illustrative of the heterocyclic radicals represented by 31 are the following: piperidino; (lower alkyl)piperidino [e.g., 2-, 3-, or 4-(lower alkyl)piperidino or 4-(N-lower alkyl )-piperidino, such as 2-(ethyl)piperidino or 4-(N- isopropyl)-piperidino]; di(lower alkyl)piperidino [e.g., 2,4-, 2,5- or 3,5-di(lower alkyl)piperidino, such as 2,4- dimethyl piperidino or 2,5-di-t-butyl piperidino]; (lower alkoxy)piperidino [e.g., 2-methoxypiperidino or 3-methoxypiperidino]; hydroxypiperidino [e.g., 3-
hydroxy- 'or 4-hydroxypiperidino]; aminomethylpiperidino [e.g., 4-aminomethylpiperidino]; pyrrolidino; (lower alkyl)pyrrolidino [e.g., 3-
methylpyrrolidino]; di(lower alkyl)pyrrolidino [e.g., 3,4-dimethylpyrrolidino];- (lower alkoxy)pyrrolidino [e.g., 2-methoxypyrrolidino]; morpholino; (lower alkyl)morpholino [e.g., 3-methylmorpholino]; di(lower alkyl)morpholino, [e.g., 3,5-dimethylmorpholino]; (lower alkoxy)-morpholino, [e.g., 2- methoxymorpholino]; thiamorpholino; (lower alkyl)- thiamorpholino [e.g., 3-methylthiamorpholino]; di(- lower alkyl)thiamorpholino, [e.g., 3,5- dimethylthiamorpholino], (lower alkoxy)thiamorpholino, [e.g., 3-methoxythiamorpholino]; piperazino; (lower alkyl)piperazino, [e.g., N-methylpiperazino]; di(lower alkyl)piperazino, [e.g., 2,5- dimethylpiperazino or 2,6-dimethylpiperazino]; (lower alkoxy)piperazino,[e.g., Z-methoxypiperazino]; (hydroxy-lower alkyl)piperazino, [e.g., N-(2- hydroxyethyl)piperazino]; (lower alkanoyloxy-lower alkyl)-piperazino, [e.g., N-(2-heptanoyloxyethyl)- piperazino or N-(2-propionyloxyethyl)piperazino]; (hydroxy-lower alkoxylower alkyl)piperazino, [e.g., (hydroxymethoxymethyl)piperazino]; (carbo-lower alkoxy)piperazino, [e.g., N-(carbomethoxy-, carboethoxy-, or carbopropoxy)piperazino]; piperidyl; (lower alkyl)piperidyl [e.g., 1-, 2-, 3- or 4-(lower alkyl)- piperidyl, such as l-N-methylpiperidyl or 3- ethylpiperidyl]; di(lower alkyl)piperidyl, [e.g., 2,4-, 2,5. or 3,5-di(lower alkyl)-piperidyl wherein lower alkyl is methyl, ethyl, n-propyl, isopropyl, etc]; lower alkoxy piperidyl, [e.g., 3-methoxypiperidyl or 2- 4 ethoxypiperidyl]; hydroxypiperidyl [e.g., 3-hydroxyor 4-hydroxypiperidyl]; aminomethylpiperidyl,[e. g. 4, -aminoethylpiperidyl]; pyrrolidyl, lower alkyl pyrrolidyl, [e.g., l-N-methylpyrrolidyl]; di(lower alkyl)pyrrolidyl, [e.g., 2,3-dimethylpyrrolidyl]; lower alkoxy pyrrolidyl, [e.g, 4-N-methoxypyrrolidyl]; morpholinyl; (lower alkyl)-morpholinyl, [e.g., 3- methylmorpholinyl]; di-(lower alkyl)-morph0linyl, [e.g., 3-methyl-4-N-ethylmorpholinyl1; (lower alkoxy)- morpholinyl, [e.g, 2-ethoxymorpholinyl]; thiamorpholinyl; (lower alkyl)thiamorpholino, [e.g., 3- ethylthiamorpholinyl]; di(lower alkyl)thiamorpholinyl, [e.g., 3-methyl-4-N-ethylthiamorpholinyl]; lower alkoxy thiamorpholino, [e.g., 3-methoxythiamorpholinyl1; piperazinyl; alkyl, dialkyl, alkoxy or hydroxy-lower alkyl substituted piperazinyl.
The compounds of formula I form acid addition salts with inorganic and organic acids. These acid addition salts frequently provide useful means for isolating the products from reaction mixtures by forming the salt in a medium in which it is insoluble.- The free base may then be obtained by neutralization, e.g., with a base such as sodium hydroxide. Then any other salt may again be formed from the free base and the appropriate inorganic or organic acid. Illustrative are the hydrohalides, especially the hydrochloride and hydrobromide which are preferred, sulfate, nitrate, phosphate, borate, acetate, oxalate, tartrate, maleate, citrate, succinate, benzoate, ascorbate, salicylate, methanesulfonate, benzenesulfonate, toluenesulfonate and the like. Quaternary ammonium salts are also formed, e.g., by reacting the free base with an alkylating agent, e.g., lower alkyl halide such as methyl chloride, ethyl bromide or the like, lower alkyl sulfate such as methyl sulfate, aralkyl halides such as benzyl chloride, aralkyl sulfates such as benzyl sulfate and the like.
Preferred are those compounds wherein R, R, R R R R R, R and R are all hydrogen, R is hydrogen or lower alkyl especially hydrogen, R is lower alkyl, especially isopropyl, and X is O, Y is O and Z is and the aminopropanol C me 1- or a-position.
In all of the above embodiments of the invention, the X-Z-Y group will be attached to the cycloalkyl ring on two vicinal carbon atoms.
The new compounds of this invention are useful as water softeners and for inhibiting the corrosivity of engine lubricants.
They are also useful as central nervous system depressants and antifibrillatory agents, for example, in arresting cardiac arrhythmia in mammals, e.g., by inhibition of beta adrenergic receptors in the myocardium. For these purposes a compound of formula I or a physiologically acceptable acid addition salt may be incorporated in a conventional dosage form such as tablet, capsule, elixir, injectable or the like along with the necessary carrier material, excipient, lubricant, buffer or the like. Single or divided doses of about 5 to 25 mg/kg/day, preferably about 4 to 10 mg/kg, two to four times daily may be administered in dosage forms as described above.
Compounds of formula I can be prepared by reacting a phenol of the structure (IV) R (011),,
Z l l v gl lal isehlorine or bromine), such as epichlorohydrin in a solvent such as dimethylsulfoxide (as described herein) to form l,2,3,4-tetrahydro5-[2,3-epoxy propoxy]-naphthalenes of the structure v R 0 /R3 R11 0-'-C--C 15 /X\ a 5 'u Rt 2 (C lu 2O Rm a The above epoxy-propoxy-naphthalene can be converted to the formula I compounds of the invention by heating with an amine VII R H R2 in an inert organic solvent, such as n-propanol, benzene or toluene, e.g., for about 16 to 24 hours; the reactants may also be heated in a Parr pressure reactor at a temperature within the range of from about 70 to about 1 10 for 6 12 Compounds of formulae 1 and Ill wherein Z is prescut, that is In e R1 a /Rl QJLJPLN X a 1 1 Lil j where Z is R12 BIL-CH 'or C I X3 can be prepared by reacting a compound of formula ll, that is 11 m R R" R 0+ wag M H 1h R1 z with a ketone or an aldehyde of the structure R12 \C=O or IW-CHO R" VIII IX wherein R and R are the same or different and can be lower alkyl. monocyclic aryl or lower alkylmonocyclic aryl in the presence of asolvent boiling below ahout C. such as benzene or chloroform to form an oxaz olidine compound of the structure X 3 R0117 Rs R11 o h b cn R8 in I l-R Z O -11" cim n n Compounds of formula lll wherein Z is or S=C/ can be prepared by reacting compounds of formula ll with phosgene (COCl or thiophosgcnc (CSCl to form compounds of the structure XI R0 R1 R3 X gal n where Z is O or S.
Alternatively, compounds of structure I can be pre- I pared by reacting a starting material of structure [V with a compound of the structure XII XII R6 R1 R3 of the R4 l I which are epoxidized by reaction with a suitable oxidizingagent such as m-chloroperbenzoic acid or other peracid in a solvent such as chloroform. to compounds of structure Vl. This method is particularly useful where R. R and/or R are other than hydrogen and R and R are hydrogen.
The cyclic polymethylene phenols of structure lV employed as starting materials herein are disclosed in copending application Ser. No. 268,300, filed July 3, 1972 entitled TRlCYCLlC TETRAHYDRO NAPH- THALENEOLS AND RELATED COMPOUNDS.
Preferred compounds of the invention include those having the structure to form ethers XIII structure Rn X EXAMPLE 1 3a.9a-cis-1-(tert-Butylamino)-3-[(3a, 4,9,9atetrahydro-Z, 2-dimethyl-2H-naphtho[2,3-d]dioxol-5- yl)-oxy]-2-propanol A. cis-5,6,7,8-Tetrahydro-1,6,7-naphthalenetriol A solution of 29.2 g. (0.2 mole) of 5,8-dihydro-1- naphthol and 40 ml. of acetic anhydride in 100 ml of pyridine is prepared. After 16 hr. the solvent is removed in vacuo and the residue dissolved in ether and washed with 200 ml. of 5% hydrochloric acid, water, 200 ml. of 10% sodium hydroxide, saturated salt solution and dried. Solvent removal gives 34.2 g (90.5) of crude acetate which is dissolved in 900 ml. of acetic acid and 36 ml. of water. 53.3 g. (0.32 mole) of silver acetate is added followed by 40.6 g. (0.16 g-atom) of iodine. The slurry is heated with good stirring at 85: 10 for 3 hr. under nitrogen, cooled and filtered. The filtrate is evaporated in vacuo and the residue dissolved in 250 ml. of methanol and cooled to A solution of 40 g. of sodium hydroxide in 200 ml. of water is added under nitrogen and the mixture stirred overnight. The bulk of the methanol is removed in vacuo whereupon a solid forms. The solid is separated by filtration, dissolved in 150 ml. of water and acidified with 20 ml. of concentrated hydrochloric acid. Cooling gives a solid which is filtered and dried to give 16.5 g. 2,3 cis- 5 ,6,7,8-tetrahydro-l ,6,7-naphthalenetriol m.p. 184.5-187. Three recrystallizations from absolute ethanolgive the analytical sample, m.p. 188-188.5".
Anal. Calcd for C1QH|2O3: c, 66.65; H. 6.71
Found: C, 66.19; H, 6.68
B. Acetonide, of cis-5,6,7,8-tetrahydro-l,6.7- naphthalenetriol A slurry of 5.4 g of the cis-5,6,7,8-tetrahydro-l,6,7- naphthalene-triol in 50 ml of 2,2-dimethoxy propane is treated with 150 mg. of TsOH (solution in min).
After 1 hr. the solution is partitioned between ether and satd bicarbonate solution. The organic layer is dried and evaporated to give 6.58 g. essentially TLC homogeneous. Crystallization of a small sample from hexane/ethyl acetate gives the title material of mp. 130.5-13l.5.
C. Acetonide of 3-(5,6,7,8-tetrahydro-cis-6,7- dihydroxynaphthoxy)-1,Z-epoxypropane A solution of 5.8 g (0.026 mole) of the above phenol and 1.51 g (0.028 mole) of sodium methoxide is prepared in 100 ml of methanol and the solvent removed in vacuo. The residue is dissolved in 75 ml of DMSO, ca. ml distilled out (40 at 0.2 mm) and 4 ml of epichlorohydrin added. After stirring overnight at room temperature under nitrogen the solution is poured into 1.2 liters of water and extracted with ether (2 X 250 ml). The ether is washed twice with water, dried and evaporated to give 7.2 g of tan oil of the above title.
D. 3a,9a-cis-l-(tert-Butylamino)-3-[(3a, 4,9,9atetrahydro-2,Z-dimethyI-ZH-naphthol2,3-dldioxol-S- yl)-oxyl]-2-propanol The above epoxide is heated at 80 5 in the small Parr bomb with 45 ml of t-butyl amine for 16 hours. The excess amine is removed in vacuo and the residue crystallized from a mixture of hexane and ether to give 3.3 g. Recrystallization from 100 ml of 10-15% ether in pentane gives 1.5 g, mp 85-88.
Anal. Calcd for C H N0 C, 68.74; H, 8.94; N,
4.01. Found: C, 68.71; H, 9.06; N, 3.79.
EXAMPLE 2 3a,9a-cis-l-(tert-Butylamino)-3[(3a,4,9,9atetrahydro-2-propyl-2H-naphtho[2,3d]dioxol-5-yl)- oxy]-2-propanol A. O ,O -Butylidene-5 ,6,7,8-tetrahydro-l ,6,7- naphthalenetriol A solution of 3.6 g (0.02 moles) of the triol of Example l-A in 50 ml. of benzene, and 1.5 of butanal in the presence of 0.1 g p-toluene sulfonic acid are mixed together and stirred for several hrs. Water is removed by azeotropic distillation and the residue is taken to dryness to yield the title compound.
B. 3a,9a-cis-l-(tert-Butylamino)-3[(3a,4,9.9atetrahydro-2-propyl-2H-naphtho[2,3d]dioxol-5-yl)- oxy]-2-propanol I The procedure of Example 1C and D is followed in employing the triol of part A to form the title compound.
EXAMPLE 3 3a,9a-cis-1-(tert-Butylamino)-3[(3a,4,9,9atetrahydro-2-diethylaminomethyl)-2H- naphtho[2,3d]dioxol-5yl)-oxy]-2-propan0l A. 6,7-B-chloroethylidene-5,6,7,8-tetrahydro-1,6,7- naphthalenetriol A solution of 27 g (0.15 moles) of cis-5,6,7,8- tetrahydro-1,6,7-naphthalenetriol prepared as described in Example 1 in 250 ml of benzene and 25 g of diethoxyethyl' chloride in the presence of 0.2 g ptoluene sulfonic acid are mixed together for several hours. Water is removed by azeotropic distillation and the residue taken to dryness to yield the title comound.
B. O. O -B-Diethylaminoethylidene-5,6,7,8- tetrahydro-1,6,7-naphthalenetriol The procedure described in J. Pharm and Pharmac. 23, 649 (1971) is followed.
The haloacetal from part A is dissolved in ethanol containing excess diethylamine and the mixture heated at C for 48 hours in a bomb. The mixture is cooled and water and solvent stripped therefrom. The residue is purified bychromatography on Alumina 11 neutral to yield the title compound.
C. 3a,9a-cis-1-(tert-Butylamino)-3[(3a,4,9,9atetrahydro-2-diethylaminomethyl)-2H- naphtho[2,3d]dioxol-5-yl)-oxy]-2-propanol The procedure of Example 1C and D is followed employing the triol of part B to form the title compound.
EXAMPLE 4 3a,9a-cis-1-(iso-Propylamino)-3-[3a,4,9,9atetrahydro-2H-naphtho[2,3d]dioxol-2-one-5yl]-oxy]- 2-propanol A. 5,8-Dihydro-l-naphthol, benzyl ether A solution of 5,8-dihydro-l-naphthol (73 g., 0.5 M) in 400 ml. DMSO is treated with 0.5 M ofsodium methoxide. The mixture is cooled in an ice bath while benzyl bromide (85.5 g., 0.5 M) is added dropwise. The mixture has to be shaken periodically since there is difficulty in stirring. Toward the end of the addition the mixture is allowed to warm to -45", and stirring is continued for 2-3 hours after addition is complete. The mixture is then poured into 1 liter H 0 and the product is extracted into ether. The ether extracts are washed with 10% NaOH, dried and the solvent is removed in vacuo to give a' quantitative yield of crude crystalline product.
. obtained.
A small sample (4g) of this is recrystallized twice from methanol to give the title compound, 1.3 g., mp 70-74.
Anal. Calcd for C H O:C, 86.40: H, 6.83
Found: C, 86.58; H, 6.6
B. cis-5,6,7,8-tetrahydro-l,6,7-naphthalenetriol-O'- benzyl ether To 47.2 g (0.20 mole) of the above ether dissolved in 900 ml of acetic acid containing 30 ml of water is added 53.3 g (0.32 mole) of silver acetate with vigorous stirring followed by 40.6 g (0.16 g. atom) ofiodine. After 1 hour, the slurry is heated to 8595 for 3 hours under nitrogen, cooled and filtered. The filtrate is taken to dryness in vacuo and the residue taken up in 250 ml of methanol and treated in the cold with a solution of 40 g of sodium hydroxide in 200 ml of water. After stirring overnight, the bulk of the methanol is removed in vacuum, and the product extracted into chloroform. After dyring and solvent removal, the product is induced to crystallize by trituration with hexane.
C. 5,6,7,8-Tetrahydro-l ,6.7-naphthalenetriol-O- benzyl ether-O ,O -carbonate in accordance with the procedure set out in Arch. Pharm. 304 590 (1971 a solution of 27 g (0.1 mole) ofthediol of part B (0.1 m)-in 200 ml of THF is treated with 1.7 g (0.1 m) of N,N-carbonyl diimidazole and heated under reflux for 2 hours. After cooling, the mixture is poured into water and the productextracted into CHCl dried and purified on deactivated silica gel to give the title compound.
D. 3a,9a-cis-l-(iso-Propylamino)-3-[3a,4,9,9atetrahydro-2H-naphtho[2,3d]dioxol-2-one-5yl]-oxy]- 2-propanol g The procedure of Example 1C and D (substituting isopropylamine for t-butylamine) is followed employing the above carbonate to form the title compound.
EXAMPLE 5 3a,9a-cis-l-(iso-Propylamino)-3-[3a,4.9,9atetrahydro-2-ethyl-2-methyl-2H-naphtho[2,3d]dioxol- 6yl)-oxyl]-2propanol A. 5,8Dihydro-2-naphthol I The procedure of Marshall, et al., Can. J. Chem., 47. 3127 1969) is followed exactly. From 25.0 g of B-naphthol is obtained 18.9 g of crude product. NMR analysis indicated it to contain ca. 40%.of the desired 5,8-dihydro-2-naphthol an 60% of 5,6,7,8-tetrahydro- 2-naphthol.
B. cis-5,6,7,8-Tetrahydro-2,6,7-naphthalene triol The 18.9 g. of crude product was converted to the acetate by the procedure used in Example 1 and the resulting oil (23.8 g) was heated at 90 for 3 hr. with 300 ml. of aceticacid, 20 ml. of water, 23.5 g. of silver acetate and 18.0 g. of iodine. The slurry was cooled and filtered. The filtrate was evaporated and the residue stirred overnight under nitrogen with 100 ml. each of water and methanol and 20 g. of sodium hydroxide. The methanol was removed in vacuo and the residue acidified at with 155 ml. of 122 hydrochloric acid. The oil which separated crystallized when shaken in a separatory funnel with chloroform. Filtration gave 7.9 g. of tan solid. Recrystallization from ethanol/ethyl acetate gave in several crops 4.03 g., mp l93195.5.
C. 0 0 -2-Butylidene-5,6,7,8-tetrahydro-2,6,7- naphthalenetriol Following the procedure of Example 2 substituting for butanal, methyl ethyl ketone, the title compound is D. 3a,9a-cis-l-(iso-Propylamino)-3-[3a,4,9,9atetrahydro-2-ethyl-2-methyl-2H-naphtho[2,3d]dioxol- 6yl)-oxy]-2-propanol The procedure of Example 4D is followed employing the above triol to form the title compound.
EXAMPLE 6 3a,9a-trans-l-(tert-Butylamino)3-[3a,4,9,9atetrahydro-2,2-dimethyl-2H-naphtho[2,3dl-l-thia-3- oxol-5(and 8)-oxy]2-propanol A. 6,7-Epoxy-5,6,7,8-tetrahydro-l-naphthyl benzyl ether A solution of73 g. (0.5 m)of5,8-dihydro-1-naphthol in ml. DMSO is treated with 0.5 in sodium methoxide. The mixture is cooled in an ice bath and treated dropwise with 0.5 mole benzyl bromide with shaking periodically. The mixture is gradually allowed to warm up to about 45 toward the end of addition. The mixture is stirred 3 hrs. longer, then poured into 1 liter H 0 and extracted into ether. Extracts are washed twice with 10% NaOH, dried, taken to dryness leaving almost a quantitative yield of crystalline 5,8-dihydro-lnaphthyl benzyl ether.
A solution of 23.6 g. (0.10 m') of the above ether in 250 ml. CHCl is treated with a solution of 0.11 m mchloroperbenzoic acid in Cl-lCl at 10-l5C and stirred overnight. After filtration, the organic filtrate is washed with dilute K CO dried and freed of solvent, leaving crude solid epoxy ether.
B. 7(and 6)Mercapto-S,6,7,S-tetrahydronaphthalene-l,6,(and 7)diol A solution of the above epoxyether (12.6 g. 0.05 m) in ethanol was added to an aqueous solution of sodium sulfide and the resulting mixture warmed for serveral hours. After cooling and acidification with acetic acid, the product was extracted into Cl-ICl dried and freed of solvent to leave a mixture of isomeric mercapto alcohols of I structure:
and HS rnoy EXAMPLE 7 3a, 9a-trans-l-(iso-Propylamino)-3[3a.4,9,9atetrahydro-2-butyl-2-methyl-2H-naphtho[2,3d]-l-thia- 3-oxol-5(and 8)yl)oxy]-2-propanol A. S.O-2-Hexylidene--mercapto-S,6,7,8- tetrahydronaphthalenel ,7-diol Employing the mercaptan prepared in Example 68 in lieu of the l,2,3,4-tetrahydro-l ,2,5-naphthalenetriol in the procedure of Example 2, and replacing the butanal with methyl butyl ketone, the following compound is obtained 11 (Ina (In: S on3 \C/ W CH3 4Ha\ 04H, 0
B. 3a,9a-trans-l-(iso-propylamino)-3[3a.4,9,9a-
tetrahydro-2-butyl-2-methyl-2H-naphtho[2,3d]-l -thia- 3oxol-5(and 8)oxy]-2-propanol The procedure of'Example 1C and D is-followed em-- ploying the above diol to form the title compound.
EXAMPLE 8 3a,9a-tran s-l-(iso-Propylamino)-3[3a,4,9,9atetrahydro-2-diethylaminomethyl-2H-naphtho[2,3d]- l thia-3-oxol-5(and 8)yl)-oxy]-2-propanol A. S,O -B-Ch|oroethylidene-6-mercapto-5,6,7,8- tetrahydronaphthalene-l .7-diol Employing the mercaptan prepared in Example 6B in lieu of cis-5,6.7.8-tetrahydro-l,6,7-naphthalenetriol in the procedure of Example 3. the following compound is obtained on O B. 3a,9a-trans-l-(iso-Propylamino)-3[3a,4,9,9atetrahydro-2-diethylaminomethyl 2H-naphtho[2.3d]- l-thia-3-oxol-5(and 8)-yl)-oxy]-2-propanol The procedure of Example 4D is followed by employing the above diol to form the title compound.
EXAMPLE 9 3a,9a-trans-l-(iso-Propylamino)-3[3a,4,9,9atetrahydro-2H-naphtho[2,3d]-l-thia-3-oxol-2-one- 5(and 8)-yl)oxy]-2-propanol A. 6-Mercapto-5,6,7,8-tetrahydronaphthalene-l,7- diol S,O -carbonate-O'-benzyl ether Employing the benzyl ether of the mercaptan of Example 6B in the procedure of Example 4 in lieu of the diol, the following compound is obtained ClCHg-C O CH: C6H5 0 S ace 3a,9a-trans-l-(iso-Propylamino)-3[3a,4,9,9atetrahydro-2H-napht ho[2,3d]-l-thia-3-oxol-2-one- 5(and 8)-yl)oxy]-2-propanol The above compound is debenzylated by reaction with Pd/C in the presence of pyridine and the resulting diol is subjected to the procedure of Example 1C and D to form the title compound.
EXAMPLE l0 7-Hydroxy-l(and 4)-(2-hydroxy-3'-tert butylamino propoxy)-5.6.7.8tctrahydro-fi-naphthyloxyacetic acid lactone A. 7(and 6)Hydroxy-S.6,7.8-tetrahydro-6( and 7 )-naphthyloxyacetic-acid lactone The above compound is prepared by reacting 0.] mole 5.6,7,8-tetrahydro-l,6,7-naphthalenetriol O'- benzyl ether with 0.] mole of Cl-CH CO C H in I00 ml of dimethoxyethane in the presence of 3 g NaH and heating the mixture at reflux for several hours and thereafter separating the product from the reaction mixture by chromatography on silica gel.
Catalytic debenzylation over 5% Pd/c in ethanol then affords the free phenol.
B. 7-Hydroxy-l(and 4)-(2-hydroxy-3'-tert butylamino propoxy)-5,6,7.S-tetrahydro-o-naphthyloxyacetic acid lactone The procedure of Example lC and D is followed cmploying the above phenol to form the title compound.
EXAMPLE ll EXAMPLE l2 3a,9a-trans-l-(iso-Propylamino)-3[(3a,4,9,9atetrahydro-2H-naphtho[2,3d]-l-thia-3-oxol-2-thion- 5(and 8)yl)oxy]-2-propanol A. 6-Mercapto-5,6.7,8-tetrahydro-naphthalene-l,7- diol-O-benzyl ether O ,S-thiocarbonate The procedure of Examples 9 and 4 are followed employing the benzyl ether of the mercaptan of Example 68 and thiophosgene in place of phosgene to form the above compound.
B. 3a.9a-trans-l-(iso-Propylamino)-3[(3a,4,9,9atetrahydro-2H-naphtho[2.3d] l -thia-3-oxol-2-thion- 5(and 8)yl)oxy1-2-propanol Catalytic debenzylation of the benzyl ether over 5% Pd on C in the presence of ethanol yields the free phenol. The free phenol is subjected to the procedure of Example 4D to form the title compound.
EXAMPLE l3 3a,9a-trans-l-(tert-Butylamino)-3[93a,4,9,9atetrahydro-2H-naphtho[2,3d]-l-oxy-3-azol-2-one- 5(and 8)yl)oxy]-2-propanol A. 6(and 7)-Amino-5,6,7,8-tetrahydronaphthalenel,7-(and 6)-diol-O-benzyl ether 0 N-carbonate A solution of 0.1 m each of the epoxide benzyl ether of Example 6A and phenyl isocyanate in xylene is added to a solution containing 0.004 m oftributyl phosphine oxide and 0.003 m of lithium bromide in xylene and the mixture heated under reflux overnight. After cooling, solvent is removed and the crude mixture of products purified on neutral Alumina III to give the title compound.
Method Ref. 'l'el. Letters 809 (1971) B. 3a,9a-trans-l-(tert-Butylamino)-3[(3a,4,9,9a-
nol. The free phenol is subjected to the procedure of 5 Example 1C and D to form the title compound.
EXAMPLE l4 3a,9a-trans-l-(tert-Butylamino)-3[3a,9,9a-tetrahydro- ZH-naphtho [2,3d]-l-oxa-3-azol-2-thion-5-(and 8)yl)- oxyl-2-propanol A. 6-Amino-5,6,7,8-tetrahydronaphthalene dio1-O-benzyl ether O,N-thiocarbonate A solution of 0.l m each of the epoxide benzyl ether of Example 6A and butylisothiocyanate in xylene added to a solution containing 0.004 m of tributyl phosphine oxide and 0.003 m of lithium bromide in xylene and the mixture heated under reflux overnight. After cooling, solvent is removed and the crude mixture of products purified on neutral Alumina lll to give the title compound.
Method Ref. Tet. Letters 809 (1971).
B. '3a,9a-trans-l-(tert-Butylamino)-3[3a,4,9,9atetrahydro-2H-naphtho[2,3d]-l-oxa-3-azol-2-thion- 5(and 8)yl)-oxy]-2-propanol Catalytic debenzylation of the above benzyl ether over 5% Pd and C in the presence of ethanol yields the free phenol. The free phenol is subjected to the procedure of Example 1C and D to yield the title compound.
EXAMPLE l5 3a,9a-cis-l-(tert-Butylamino)-3[3a,4,9,9a-tetrahydro- 2-phenyl-lH-naphth[2,3d]oxazol-5(and 8 )yl)oxy]-2- propanol A. 6,7-Epoxy-5,6,7,8-tetrahydro-l-naphthol benzyl ether A solution of 12.8 (0.054 m) of 5,7-dihydro-lnaphthol benzyl ether in 150 ml of CH CI was cooled to and 8.9 g 0.052 mole ofm-chloroperbenzoic acid was added over a period of 5 min. and the mixture was stirred overnight at room temperature.
The suspension was poured into a mixture of 50 ml of NaOH and 100 g of ice. The aqueous layer was extracted with CH Cl and the combined organic layers were washed with water and satd. NaCl soln, dried and evaporated in vacuo to give the title compound.
B. trans 6(and 7)-Amino-5,6,7,8-tetrahydro-ll,7(and 6)-naphthalenediol A solution of 6,7-epoxy-5,6,7,8-tetrahydro-1- naphthol O-benzyl ether 12.6 g (0.05 mole) in 200 ml dioxane was heated to 40 and a solution of sodium azide (6,8 g, 0tll mole) in water ml) was added dropwise. The mixture was heated under reflux overnight, cooled, filtered and the solvent was removed in vacuo.
The crude azide was dissolved in 100 ml of ether and added to a suspension of L'AH (5 g) in 250 ml of ether. After several hours at reflux, the mixture was decomposed with aqueous potassium carbonate and the filtrate freed of solvent.
C. C-Phenylimidazole derivative of 6-amino-5,6,7,8- tetrahydronaphthalenel ,7-diol O-benzyl ether The trans amino alcohol was converted to its N- benzoyl derivative with benzoyl chloride-pyridine. This is added portionwise to excess thionyl chloride and then kept at 5060 for 3 hrs. Removal of excess reagent in vacuum leaves the crude cis oxazoline as its HCl salt, which is recrystallized from ethanol-ether.
D. 3a,9a-cis-l (tert-Butylamino)-3[3a,4,9,9a tetrahydro-2-phenyl-lH-naphth[2,3d]oxazol-5(and 8)yl)oxy]-2-propanol Catalytic debenzylation of the above benzyl ether over 5% Pd/C in the presence of ethanol yields the free phenol which is converted to the title compound by the procedure of Example 1C and D.
EXAMPLE l6 l-(tert-Butylamino)-3[3a,4,9,9a-tetrahydro-2-aminol-H-naphth-[2,3d]oxazol-5(and 8)yl)oxy]-2propanol A. Aminooxazoline derivative of 6(and 7)amino- 5,6,7,8-tetrahydronaphthalene-l,7(and 6)diol An intimate mixture of 12.6 g (0.05 mole) of 6,7- epoxy-5,6,7,8-tetrahydro-l-naphthyl benzyl ether and 25 g of guanidine are heated to l40l80C until gas evolution ceases. The reaction mixture is cooled, and the product recrystallized from alcohol.
B. l-(tert'Butylamino)-3[3a,4,9,9a-tetrahydro-2- amino-1-Hnaphth[2,3d]oxazol-5(and 8)yl)oxy]-2- propanol The free phenol obtained on catalytic debenzylation is subjected to the procedure of Example 4D to form the title compound.
EXAMPLE 1 7 6-Hydroxy-5(and 8)-(2-hydroxy-3-butylaminopropoxy)-5,6,7,8-tetrahydronaphthalene-7-acetic acid lactone A. 1,7(and 6)Dihydroxy-5,6,7,8-tetrahydro-6(and 7)-naphthalene-acetic acid lactone A solution of 12.6 g (0.05 mole) of 6,7-epoxy' 5,6,'7,S-tetrahydronaphthol benzyl ether and 7.5 g (0.05 mole) of diethylmalonate in ml of absolute ethanol containing about 0.01 mole of sodium ethoxide was brought to reflux for several hours. The mixture was cooled, treated with concentrated HCl and warmed to effect hydrolysis and decarboxylation. Removal of solvent left crude lactone which was purified by chromatography on silica gel.
Catalytic debenzylation over 5% Pd on C in ethanol provided the free phenol.
B. 6- Hydroxy-5(and 8)-(2-hydroxy-3-butylaminopropoxy)-5,6,7,8-tetrahydronaphthalene-7-acetic acid lactone The procedure of Example 1C and D is followed employing the above phenol to form the title compound.
EXAMPLE l8 EXAMPLE l9 Bis acetonide derivative of the product of Example 1 The product of Example 1 is dissolved in acetone in v the presence ofa catalytic amount of p-toluene sulfonic acid and the mixture is refluxed to form the title compound.
EXAMPLE 20 The Bis-butylidene derivative of 2,3-cis-l,2,3,4- tetrahydro-5-[2-hydroxy-3-(tert-butylamino)- propoxy]-2,3-naphthalenediol A. cis-5,6,7,8-Tetrahydro-1,6,7-naphthalenetriol A solution of 29.2 g. (0.2mole) of 5,8-dihydro-lnaphthol and 40 ml. of acetic anhydride in 100 ml. of pyridine is prepared. After 16 hr. the solvent is removed in vacuo and the residue dissolved in ether and washed with 200 ml. of 5% hydrochloric acid, water, 200 ml. of 10% sodium hydroxide, saturated salt solution and dried. Solvent removal gives 34.2 g. (90.5%) of crude acetate which is dissolved in 900 ml. of acetic acid and 36 ml. of water. 53.3 g. (0.32 mole) of silver acetate is added followed by 40.6 g. g. (0.16 g-atom) of iodine. The slurry is heated with good stirring at 85: 10 for 3 hr. under nitrogen, cooled and filtered. The filtrate is evaporated in vacuo and the residue dissolved in 250 ml. of methanol and cooled to A solution of 40 g. of sodium hydroxide in 200 ml. of water is added under nitrogen and the mixture stirred overnight. The bulk of the methanol is removed in vacuo whereupon a solid forms. The solid is separated by filtration, dissolved in 150 ml. of water and acidified with 20 ml. of concentrated hydrochloric acid. Cooling gives a solid which is filtered anddried to give 16.5 g. 2,3cis-5,6,7,8- tetrahydro-l,6,7-naphthalenetriol) m.p: 184.5187. Three recrystallizations from absolute ethanol give the analytical sample, m.p. 188l88.5.
Anal. Calcd for C H O C, 66.65; H, 6.71
Found: C, 66.19; H, 6.68.
B. 2,3-cis-l,2,3,4-Tetrahydro-5-[2,3-(epoxy)- propoxy]-2,3-naphthalenediol A solution of 1.20 g. (0.03 mole) of sodium methoxide and 5.4 g. (0.03 mole) of cis-5,6,7,8-tetrahydro- 1,6.7--naphthalenetriol in 200 ml. of methanol is prepared under nitrogen. The residue obtained upon solvent removal is stirred overnight with 200 ml. of dimethylsulfoxide and 4.65 g. (0.05 mole) of epichlorohydrin under nitrogen. The bulk of the solvent is removed at 50 at 0.1 mm. and the residue dissolved in 100 ml. of water. Extraction with chloroform X 200 ml.) gives a solid which is recrystallized from 150 ml. of hexane-ethyl acetate to give epoxy diol of the above title.
C. 2,3-cis-l,2,3,4-Tetrahydro-5-[2-hydroxy-3-(tertbutylamino)-propoxy]-2,3-naphthalenediol A mixture of 3.0 g. of 2,3-cis-1,2,3,4-tetrahydro-5- [2,3-(epoxy)-propoxy]-2,3-naphthalenediol (m.p. 104-107, one spot on TLC-alumina, 5% methanol in chloroform, iodine visualization) and 22 ml of t-butyl amine is heated at 85-95 for hours in a Parr bomb and the excess amine removed in vacuo. The solid obtained by trituration of the residue with ether is filtered and recrystallized from benzene to give 3.4 g, m.p. 124-l36.
l. A compound having the structure R3 0CH1CH(]J-NR2 0 R11 I I4 H V R! on R i/ R17 Ru RIO or a physiologically acceptable acid-addition salt thereof, wherein R is lower alkyl; R and R are hydrogen or methyl; R, R and R are each hydrogen or a non-tertiary lower alkyljR is hydrogen, lower alkyl or.
phenyl-lower alkyl; R and R are each hydrogen or lower alkyl; and wherein lower alkyl is alkyl having up to eight carbon atoms.
2. A compound having the structure or a physiologically acceptable acid-addition salt thereof, wherein R is lower alkyl; and R" and R are each selected from the group consisting of hydrogen and lower alkyl; and wherein lower alkyl is alkyl having up to eight carbon atoms.
3. A compound in accordance with claim 2 wherein R and R are lower alkyl.
4. A compound in accordance with claim 2 wherein R and R are methyl.
5. A compound in accordance with claim 2 wherein R is isopropyl.
6. A compound in accordance with claim 2 having the name 3a,9a-cis-1-(tert-butylamino)-3-[(3a,4,9,9a-
- tetrahydro-2,2-dimethyl-2H-naphtho[ 2,3-d ]dioxol-5 oxyl-2-propanol.
Part 1 of 2 Y UNITED STATES PATENT @FFKCE cERTirrcA'rt OF t.
Patent No, 3,856,818 Dated December 24, 1974 Inventor-(s) Frederic P. Hauck and Christopher M. Cimarusti It is certified that error appears in the above-identified patent and that said Letters Patent are hereby corrected as shown below:
Column 1, line v44, the word "carbon," should be: carbons,-. Column 1, lines 49 to 55, that portion of formula II that reads:
3 l 3 l R R R R I l C--N should be: C N
I 3 I 4 R 4 2 Column 1, lines 66 to 70, that portion that reads:
1-2 R R C, should be: C,
Column 4, line 44, after the word "aminopropanol" delete the letter "C" and substitute in its place: side Column 5, line 32 should read: 110 for 6-12 hours.
Column 6, line 44,- that portion reading: "R R should be:
Column 7, line 31, that portion reading: H, 6,71 should be:
Column 9, line 60, that portion reading: "122 hydrochloric acid" should be: 12% hydrochloric-acid.
Column 11, line 10, insert a hyphen after the 3 and before the word "oxol".
F ORM P04 050 (10-69) USCOMM-DC 60376-F'69 u.5. GOVERNMENT PRINTING OFFICE: I969 0-366-334.
2 2 1 Part UNlTfED STATES PATENT ormcE CERTIWCATE OF CRECTION Patent No. 856'8l8 Dated December 24, 1974 Inventor) Frederic P. Hauck and Christopher M. Cimarusti It is certified that error appears in the above-identified patent and that said Letters Patent are hereby corrected as shown below:
Column 11, line 33, insert a hyphen after the word:
"diethylaminomethyl".
' Column 12, line 29, insert: B. at the beginning of line 29..
Column 12, line 46, the line should read: tetrahydro-ZH- naphtho[2,3d]l-thia-B-oxol-Z-thion- Column 12, line 54, first line of thetitle of Example 13 should read: 3a,9a-transl(tert-Butylamino)-3[(3a,4,9,9a-
Column 13, line 9, first line of the title of Example 14 should read: 3a,9a-trans-l- (tert-Butylamino)-3[3a,4,9,9a-
tetrahydro- Column 13, line 48, at the end of the line, delete "l".
Column 14, line 55 should read: 7-acetic acid thiolactone Signed and sealed this 11th day of March 1975.
(SEAL) Attest:
Y C. MARSHALL DANN RUTH C. MASON Commissioner of Patents Attesting Officer and Trademarks DRM FO-105O (10-69)
Claims (6)
1. A COMPOUND HAVING THE STRUCTURE
2. A compound having the structure
3. A compound in accordance with claim 2 wherein R16 and R17 are lower alkyl.
4. A compound in accordance with claim 2 wherein R16 and R17 are methyl.
5. A compound in accordance with claim 2 wherein R2 is isopropyl.
6. A compound in accordance with claim 2 having the name 3a,9a-cis-1-(tert-butylamino)-3-((3a,4,9,9a-tetrahydro-2,2-dimethyl-2H -naphtho(2,3-d)dioxol-5-oxy)-2-propanol.
Priority Applications (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US00268313A US3856818A (en) | 1972-07-03 | 1972-07-03 | Tricyclic phenoxy aminopropanols |
| CA173,628A CA1000287A (en) | 1972-07-03 | 1973-06-08 | Tricyclic phenoxy aminopropanols |
| GB2818773A GB1434225A (en) | 1972-07-03 | 1973-06-13 | Tricyclic phenoxy aminopropanols |
| DE2332706A DE2332706A1 (en) | 1972-07-03 | 1973-06-27 | AMINOPROPANOL DERIVATIVES, THEIR SALTS, PROCESS FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS |
| CH963073A CH577459A5 (en) | 1972-07-03 | 1973-07-02 | |
| HUSU823A HU167178B (en) | 1972-07-03 | 1973-07-02 | |
| BE133067A BE801848A (en) | 1972-07-03 | 1973-07-03 | TRUCYCLIC PHENOXY-AMINOPROPANOLS AND THEIR PREPARATION |
| NL7309236A NL7309236A (en) | 1972-07-03 | 1973-07-03 | |
| JP48076473A JPS4955652A (en) | 1972-07-03 | 1973-07-03 | |
| FR7324448A FR2190463B1 (en) | 1972-07-03 | 1973-07-03 | |
| AR248898A AR201666A1 (en) | 1972-07-03 | 1973-07-03 | PROCEDURE FOR PREPARING DERIVATIVES OF DIMETHYLTETRAHYDRONAFTODIOXOLIL-OXY-PROPANOLES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US00268313A US3856818A (en) | 1972-07-03 | 1972-07-03 | Tricyclic phenoxy aminopropanols |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3856818A true US3856818A (en) | 1974-12-24 |
Family
ID=23022403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US00268313A Expired - Lifetime US3856818A (en) | 1972-07-03 | 1972-07-03 | Tricyclic phenoxy aminopropanols |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US3856818A (en) |
| JP (1) | JPS4955652A (en) |
| AR (1) | AR201666A1 (en) |
| BE (1) | BE801848A (en) |
| CA (1) | CA1000287A (en) |
| CH (1) | CH577459A5 (en) |
| DE (1) | DE2332706A1 (en) |
| FR (1) | FR2190463B1 (en) |
| GB (1) | GB1434225A (en) |
| HU (1) | HU167178B (en) |
| NL (1) | NL7309236A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4031225A (en) * | 1975-06-18 | 1977-06-21 | Sandoz Ltd. | 4H-Benzo[4,5]cyclohepta[1,2-b]thiophenes |
| US4548943A (en) * | 1984-05-11 | 1985-10-22 | E. I. Du Pont De Nemours And Company | Antiinflammatory, analgesic, or anti-primary dysmenorrheal arylmethylene- and arylmethylindenoimidazoles |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI833685A0 (en) * | 1983-10-11 | 1983-10-11 | Farmos Oy | FOERFARANDE FOER FRAMSTAELLNING AV EN AMINOALKOHOL |
| CA1338717C (en) * | 1989-09-25 | 1996-11-12 | Khashayar Karimian | Nadolol |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3239520A (en) * | 1961-11-20 | 1966-03-08 | Nl Combinatie Chem Ind | N-(monocarbocyclic aryloxy-lower alkyl)-n' (diloweralkyl, or heterocyclic)-lower alkylene diamines |
| US3459782A (en) * | 1963-08-26 | 1969-08-05 | Boehringer Sohn Ingelheim | 1-substituted phenoxy-2-hydroxy-3-isopropylamino-propanes |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1058822A (en) * | 1963-07-30 | 1967-02-15 | Ici Ltd | 3-amino-2-hydroxypropoxy heterocyclic derivatives |
| ES330705A1 (en) * | 1965-09-01 | 1967-10-01 | Boehringer Sohn Ingelheim | Procedure for the preparation of new substitute ariloxy-2-hydroxy-3-aminopropanes (Machine-translation by Google Translate, not legally binding) |
-
1972
- 1972-07-03 US US00268313A patent/US3856818A/en not_active Expired - Lifetime
-
1973
- 1973-06-08 CA CA173,628A patent/CA1000287A/en not_active Expired
- 1973-06-13 GB GB2818773A patent/GB1434225A/en not_active Expired
- 1973-06-27 DE DE2332706A patent/DE2332706A1/en active Pending
- 1973-07-02 HU HUSU823A patent/HU167178B/hu unknown
- 1973-07-02 CH CH963073A patent/CH577459A5/xx not_active IP Right Cessation
- 1973-07-03 FR FR7324448A patent/FR2190463B1/fr not_active Expired
- 1973-07-03 JP JP48076473A patent/JPS4955652A/ja active Pending
- 1973-07-03 BE BE133067A patent/BE801848A/en unknown
- 1973-07-03 NL NL7309236A patent/NL7309236A/xx unknown
- 1973-07-03 AR AR248898A patent/AR201666A1/en active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3239520A (en) * | 1961-11-20 | 1966-03-08 | Nl Combinatie Chem Ind | N-(monocarbocyclic aryloxy-lower alkyl)-n' (diloweralkyl, or heterocyclic)-lower alkylene diamines |
| US3459782A (en) * | 1963-08-26 | 1969-08-05 | Boehringer Sohn Ingelheim | 1-substituted phenoxy-2-hydroxy-3-isopropylamino-propanes |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4031225A (en) * | 1975-06-18 | 1977-06-21 | Sandoz Ltd. | 4H-Benzo[4,5]cyclohepta[1,2-b]thiophenes |
| US4548943A (en) * | 1984-05-11 | 1985-10-22 | E. I. Du Pont De Nemours And Company | Antiinflammatory, analgesic, or anti-primary dysmenorrheal arylmethylene- and arylmethylindenoimidazoles |
Also Published As
| Publication number | Publication date |
|---|---|
| NL7309236A (en) | 1974-01-07 |
| FR2190463B1 (en) | 1976-12-31 |
| CH577459A5 (en) | 1976-07-15 |
| JPS4955652A (en) | 1974-05-30 |
| BE801848A (en) | 1974-01-03 |
| DE2332706A1 (en) | 1974-01-24 |
| CA1000287A (en) | 1976-11-23 |
| AR201666A1 (en) | 1975-04-08 |
| GB1434225A (en) | 1976-05-05 |
| FR2190463A1 (en) | 1974-02-01 |
| HU167178B (en) | 1975-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3789072A (en) | Carboxamides | |
| US3901906A (en) | 2-(1-(2-fluoro-4-biphenylyl)ethyl)-2-oxazoline | |
| US2852510A (en) | Heterocyclic compounds and process for producing same | |
| US3856818A (en) | Tricyclic phenoxy aminopropanols | |
| US3715353A (en) | (aminoalkoxy-benzylidene)-2h-benzothiazine-3(4h)-ones and related compounds | |
| US3155649A (en) | Benzothiazocinones, related compounds and their preparation | |
| US3842090A (en) | Certain 1-aminomethyl-6-phenyl 4h-s-triazolo(4,3-a)(1,4)benzodiazepines | |
| US4082773A (en) | Tricyclic tetrahydro naphthaleneols and related compounds | |
| GB1569039A (en) | Derivatives of 10,11-dihydrobenzo(4,5)-cyclohepta(1,2-b)-pyrazolo(4,3-e)-pyridine-5(1h)one | |
| US3706755A (en) | Certain 4(3-(4-(phenyl)-3,6-dihydro-1(2h)pyridyl)-2 - hydroxy-propoxy)-benzophenones | |
| US3657276A (en) | Dibenzo (c f) thiazepine (1 2) compounds | |
| US3478048A (en) | 2,3;3a,12b - tetrahydro - 8h - dibenzo (3,4;6,7)cyclohept(1,2-d)oxazoles and derivatives | |
| US3526671A (en) | Aminoalkylated oximes of dibenzo(a,d)cyclohepten-5-ones | |
| CA1063120A (en) | Cyclic polymethylene phenoxy aminopropanols and related compounds | |
| US3435042A (en) | Novel morphanthridine derivatives | |
| US3833655A (en) | Amino-dibenzo(a,d)cyclohepta(1,4)dien-5-one compounds | |
| US3668206A (en) | Heterocyclic amine derivatives of 5,8-dihydronaphthyloxy propanols | |
| US3435073A (en) | 5-(n-benzyl-n-lower alkylaminoalkylene)-5h-dibenzo(a,d)cycloheptenes | |
| US3180867A (en) | Piperazine derivatives | |
| US3906032A (en) | Dihydroxy-tetrahydronaphthyoxyisobutyric acids and alkyl esters and salts thereof | |
| US3738999A (en) | 2,3,4,5-tetrahydro-2-phenyl-1,4-benzothiazepine, hydrochloride | |
| US5071849A (en) | Dihydropyrimidothiazine derivatives | |
| US3624086A (en) | Adamantanecarboxamidoalkanoic acid amides | |
| US2807628A (en) | Benzoxazepine compounds and method of producing same | |
| US3357982A (en) | 1-(5h-dibenzo [a, d] cyclohepten-5-yl)-4-alkylpiperazines |